Chemoinformaics analysis of 14-DEOXY-11-OXOANDROGRAPHOLIDE
Molecular Weight | 348.439 | nRot | 4 |
Heavy Atom Molecular Weight | 320.215 | nRig | 17 |
Exact Molecular Weight | 348.194 | nRing | 3 |
Solubility: LogS | -3.736 | nHRing | 1 |
Solubility: LogP | 1.992 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 56.0802 |
nHD | 2 | BPOL | 31.5618 |
QED | 0.778 |
Synth | 4.42 |
Natural Product Likeliness | 1.767 |
NR-PPAR-gamma | 0.527 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.147 |
Pgp-sub | 0.111 |
HIA | 0.134 |
CACO-2 | -5.148 |
MDCK | 0.0000123 |
BBB | 0.34 |
PPB | 0.927776 |
VDSS | 0.974 |
FU | 0.0792677 |
CYP1A2-inh | 0.023 |
CYP1A2-sub | 0.299 |
CYP2c19-inh | 0.03 |
CYP2c19-sub | 0.641 |
CYP2c9-inh | 0.11 |
CYP2c9-sub | 0.273 |
CYP2d6-inh | 0.029 |
CYP2d6-sub | 0.367 |
CYP3a4-inh | 0.055 |
CYP3a4-sub | 0.327 |
CL | 16.588 |
T12 | 0.845 |
hERG | 0.008 |
Ames | 0.019 |
ROA | 0.378 |
SkinSen | 0.162 |
Carcinogencity | 0.527 |
EI | 0.018 |
Respiratory | 0.916 |
NR-Aromatase | 0.446 |
Antiviral | Yes |
Prediction | 0.675011 |